Rchr
J-GLOBAL ID：200901034688897840   Update date: Feb. 14, 2024

Takeda Kei

タケダ ケイ | Takeda Kei
Affiliation and department：
Hiroshima University Graduate School of Biomedical Sciences, Graduate School of Biomedical Sciences

About Hiroshima University Graduate School of Biomedical Sciences, Graduate School of Biomedical Sciences


Job title： Professor
Homepage URL  (1)： http://home.hiroshima-u.ac.jp/takedake/
Research field  (1)： Pharmaceuticals - chemistry and drug development
Research theme for competitive and other funds  (4)：
  • ペリ環状反応の化学
  • ケイ素化学を基盤とする新合成方法論および試薬の開発
  • Chemistry of Pericyclic Reactions
  • Development of new synthetic methods and reagents based on silicon chemistry
MISC (139)：
ｍore...
Books (3)：
  • 化学系薬学 I. 化学物質の性質と反応
    東京化学同人 2004
  • Progress in the Total Synthesis of Spirotetronic Acid Macrolide Antibiotics, In Recent Progress in the Chemical Synthesis of Antibiotics and Related Microbioal Products, Vol.2
    Springer-Verlag 1993
  • Progress in the Total Synthesis of Spirotetronic Acid Macrolide Antibiotics, In Recent Progress in the Chemical Synthesis of Antibiotics and Related Microbioal Products, Vol.2
    Springer-Verlag 1993
Works (1)：
  • Si含有化合物の合成研究 第一製薬株式会社創薬基盤研究所
    1997 -
Education (4)：
  • - 1980 The University of Tokyo
  • - 1980 The University of Tokyo Graduate School, Division of Pharmaceutical Sciences
  • - 1975 University of Toyama Faculty of Pharmacy and Pharmaceutical Sciences School of Pharmacy
  • - 1975 University of Toyama Faculty of Pharmaceutical Science
Professional career (1)：
  • 薬学博士 (東京大学)
Work history (13)：
  • 2002 - - 広島大学大学院 教授
  • 2002 - - Hiroshima University,
  • 2000 - 2001 Hiroshima University
  • 2000 - 2001 Hiroshima University,
  • 1996 - 2000 Toyama Medical and Pharmaceutical University
Show all
Committee career (2)：
  • 2002 - 2003 日本薬学会 代議員
  • 2002 - 日本薬学会 学会賞第一次選考委員
Awards (1)：
  • 1998 - 佐藤記念国内賞
Association Membership(s) (1)：
日本薬学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM